Tag: rheumatic heart disease
Calls grow for local manufacturing as Australia faces BPG shortages
Australia is facing ongoing shortages of benzathine benzylpenicillin G (BPG), the critical treatment for syphilis and rheumatic heart disease (RHD), raising concerns over the country’s reliance on imported supplies.
Featured Article
Navigating energy price volatility with predictive intelligence
Energy price volatility has become a structural feature of modern electricity markets rather than a temporary disruption. For energy-intensive manufacturers and large commercial operators, fluctuating wholesale prices are reshaping how energy costs are managed, making reactive approaches increasingly inadequate.
